Structures by: Lemmerer A.
Total: 351
(cyclododecylammonium).(adamantanecarboxylate)
C11H15O2,C12H26N
CrystEngComm (2011) 13, 8 2849
a=28.9710(6)Å b=6.5850(1)Å c=23.0547(5)Å
α=90° β=102.386(1)° γ=90°
(N'-(cyclopentylidene)isonicotinohydrazide) .(3-hydroxybenzoic acid)
C11H13N3O,C7H6O3
CrystEngComm (2011) 13, 19 5692
a=19.7268(4)Å b=8.3772(2)Å c=10.1372(2)Å
α=90° β=98.644(2)° γ=90°
(N'-(cyclooctylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid)
C14H19N3O,C7H6O3
CrystEngComm (2011) 13, 19 5692
a=21.3902(15)Å b=7.8621(5)Å c=11.2995(7)Å
α=90° β=97.986(3)° γ=90°
(N'-(1-p-tolylethylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid)
C15H15N3O,C7H6O3
CrystEngComm (2011) 13, 19 5692
a=24.4670(16)Å b=7.3712(5)Å c=10.8211(6)Å
α=90° β=99.666(6)° γ=90°
Bis(N'-(diphenylmethylene)isonicotinohydrazide) . (3-hydroxybenzoic acid)
2(C19H15N3O),C7H6O3
CrystEngComm (2011) 13, 19 5692
a=9.8338(9)Å b=10.2475(9)Å c=10.8863(10)Å
α=104.295(8)° β=112.784(8)° γ=103.370(8)°
(N'-(propan-2-ylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C9H11N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3511(6)Å b=10.5853(8)Å c=12.8026(12)Å
α=75.694(7)° β=78.613(8)° γ=81.087(7)°
(N'-(butan-2-ylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C10H13N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3699(2)Å b=10.9498(3)Å c=12.8120(3)Å
α=81.0090(10)° β=80.5660(10)° γ=83.8590(10)°
(N'-(cyclohexylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C12H15N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3632(6)Å b=10.8918(10)Å c=13.3842(12)Å
α=87.434(7)° β=80.241(8)° γ=83.083(8)°
(N'-(cycloheptylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C13H17N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3127(4)Å b=11.4293(6)Å c=26.1598(15)Å
α=90° β=91.109(5)° γ=90°
(N'-(4-methylbenzylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C14H13N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.1506(5)Å b=10.5426(6)Å c=16.2041(12)Å
α=73.603(6)° β=90.403(6)° γ=79.320(6)°
(1,4-diammoniumbutane)tetrabromoplumbate(II)
Br4Pb,C4H14N2
CrystEngComm (2012) 14, 6 1954
a=8.0070(18)Å b=8.389(2)Å c=10.586(3)Å
α=78.572(7)° β=70.445(7)° γ=89.192(7)°
(1,4-diammonium)tetraiodoplumbate(II)
C4H14N2,I4Pb
CrystEngComm (2012) 14, 6 1954
a=21.119(4)Å b=8.5018(14)Å c=8.8936(15)Å
α=90° β=103.648(3)° γ=90°
Tetrakis(1,7-diammoniumheptane)dodecaiodotriplumbate(II) diiodide
4(C7H20N2),I12Pb3,2(I)
CrystEngComm (2012) 14, 6 1954
a=11.639(3)Å b=11.877(3)Å c=13.828(3)Å
α=68.680(5)° β=71.022(5)° γ=86.892(4)°
Bis(1,8-diammoniumoctane)tetraiodoplumbate(II)
C8H22N2,I4Pb
CrystEngComm (2012) 14, 6 1954
a=13.815(3)Å b=8.3815(15)Å c=9.0264(16)Å
α=90° β=106.749(3)° γ=90°
Bis(1,10-diammoniumdecane)tetrabromoplumbate(II)
C10H26N2,Br4Pb
CrystEngComm (2012) 14, 6 1954
a=14.651(6)Å b=7.926(3)Å c=8.455(3)Å
α=90° β=96.709(8)° γ=90°
Bis(1,12-diammoniumdodecane)tetraiodoplumbate(II)
C12H30N2,I4Pb
CrystEngComm (2012) 14, 6 1954
a=15.8186(8)Å b=8.4304(4)Å c=8.8539(4)Å
α=90° β=90.231(3)° γ=90°
Bis(1,5-diammoniumnaphthalene)tetraiodoplumbate(II)
C10H12N2,I4Pb
CrystEngComm (2012) 14, 6 1954
a=11.163(3)Å b=8.960(2)Å c=8.737(2)Å
α=90° β=90.314(4)° γ=90°
Tetrakis(1,2-diammoniumethane)nonabromodiplumbate(II) tribromide
Br9Pb2,4(C2H10N2),3(Br)
CrystEngComm (2012) 14, 6 1954
a=8.9023(8)Å b=27.727(2)Å c=14.7100(12)Å
α=90° β=102.226(6)° γ=90°
(4,4-methylenedianilinium)hexaiododiplumbate(II)
C13H16N2,2(I3Pb)
CrystEngComm (2012) 14, 6 1954
a=25.333(8)Å b=42.923(14)Å c=4.5149(15)Å
α=90° β=90° γ=90°
Bis(octadecylammonium)tetraiodoplumbate(II)
2(C18H40N),I4Pb
New Journal of Chemistry (2008) 32, 10 1736
a=8.6917(9)Å b=9.0456(10)Å c=31.424(4)Å
α=90° β=91.586(8)° γ=90°
2,6-dibromophenylthioamide
C7H5Br2NS
CrystEngComm (2009) 11, 8 1658
a=7.9801(5)Å b=8.0314(5)Å c=14.5984(9)Å
α=90° β=99.884(4)° γ=90°
4-hydroxybenzylalcohol
C7H8O2
CrystEngComm (2011) 13, 19 5773
a=9.448(7)Å b=10.894(8)Å c=5.873(4)Å
α=90° β=90° γ=90°
Tris(cycloheptylammonium)pentabromoplumbate(ii)
3(C7H16N),Br5Pb,H2O
CrystEngComm (2009) 11, 8 1549
a=8.0888(4)Å b=27.1707(15)Å c=28.9932(16)Å
α=90° β=90° γ=90°
Bis(cyclohexylammonium)tetrachloroplumbate(ii)
Cl8Pb2,4(C6H14N)
CrystEngComm (2009) 11, 8 1549
a=11.4446(11)Å b=28.306(3)Å c=11.5206(10)Å
α=90° β=90.031(6)° γ=90°
(cycloheptylammonium).(adamantane carboxylate)
C11H15O2,C7H16N
CrystEngComm (2011) 13, 8 2849
a=23.4749(10)Å b=6.4309(2)Å c=21.8759(10)Å
α=90° β=96.802(2)° γ=90°
(cyclooctylammonium).(adamantane carboxylate)
C11H15O2,C8H18N
CrystEngComm (2011) 13, 8 2849
a=6.4758(3)Å b=11.2016(6)Å c=24.5573(14)Å
α=90° β=93.217(4)° γ=90°
Bis(heptylammonium)tetraiodoplumbate(ii) PHASE IV
2(C7H18N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.589(4)Å b=8.942(4)Å c=17.243(9)Å
α=90° β=96.902(11)° γ=90°
Bis(heptylammonium)tetraiodoplumbate(ii) PHASE II
2(C7H18N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.8549(15)Å b=8.6840(19)Å c=36.612(13)Å
α=90° β=90° γ=90°
Bis(octylammonium)tetraiodoplumbate(ii) PHASE III
2(C8H20N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.4542(9)Å b=8.9916(10)Å c=18.738(3)Å
α=90° β=96.301(8)° γ=90°
Bis(nonylammonium)tetraiodoplumbate(ii) PHASE III
2(C9H22N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.7054(11)Å b=8.8401(10)Å c=19.791(3)Å
α=90° β=96.376(9)° γ=90°
Bis(nonylammonium)tetraiodoplumbate(ii) PHASE II
2(C9H22N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=9.0232(2)Å b=8.7054(2)Å c=39.7578(9)Å
α=90° β=90° γ=90°
Bis(decylammonium)tetraiodoplumbate(ii) PHASE III
2(C10H24N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.8314(2)Å b=8.4871(2)Å c=43.9491(13)Å
α=90° β=90° γ=90°
Bis(decylammonium)tetraiodoplumbate(ii) PHASE II
2(C10H24N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.8339(2)Å b=8.4845(2)Å c=43.9647(8)Å
α=90° β=90° γ=90°
Bis(decylammonium)tetraiodoplumbate(ii) PHASE II
2(C10H24N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.9807(2)Å b=8.6742(2)Å c=42.5253(14)Å
α=90° β=90° γ=90°
Bis(decylammonium)tetraiodoplumbate(ii) PHASE II
2(C10H24N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.9708(2)Å b=8.6733(2)Å c=42.5696(12)Å
α=90° β=90° γ=90°
Bis(octylammonium)tetraiodoplumbate(ii) PHASE I
4(C4H10N0.50),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.7436(3)Å b=8.7440(3)Å c=40.0276(18)Å
α=90° β=90° γ=90°
Bis(decylammonium)tetraiodoplumbate(ii) PHASE IV
2(C10H24N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.433(3)Å b=8.950(4)Å c=21.330(9)Å
α=90° β=96.107(10)° γ=90°
Bis(decylammonium)tetraiodoplumbate(ii) PHASE I
2(C10H24N),I4Pb
Dalton transactions (Cambridge, England : 2003) (2012) 41, 4 1146-1157
a=8.7152(18)Å b=8.7115(19)Å c=47.479(11)Å
α=90° β=90° γ=90°
(adamantane-1-carboxylate-3,5,7-tricarboxylic acid)(hexamethylenetetraminium) Form I
C14H15O8,C6H13N4
Chem.Commun. (2012) 48, 1883
a=17.4903(4)Å b=17.9055(4)Å c=14.3635(4)Å
α=90° β=112.635(1)° γ=90°
(adamantane-1-carboxylate-3,5,7-tricarboxylic acid)(hexamethylenetetraminium) Form II
C14H15O8,C6H13N4
Chem.Commun. (2012) 48, 1883
a=13.9430(7)Å b=11.9137(6)Å c=25.0356(12)Å
α=90° β=91.074(4)° γ=90°
((S)-1-phenylethylammonium).((2S)-[2-(4-isobutylphenyl)propanoate])
C13H17O2,C8H12N
CrystEngComm (2010) 12, 11 3634
a=5.8810(5)Å b=15.2590(6)Å c=22.318(2)Å
α=90° β=90° γ=90°
((R)-1-phenylethylammonium).(2-(2-(2,6-dichlorophenylamino)phenyl)acetate)
C14H10Cl2NO2,C8H12N
CrystEngComm (2010) 12, 11 3634
a=12.499(5)Å b=6.8934(15)Å c=13.411(6)Å
α=90° β=113.73(3)° γ=90°
((R)-1-phenylethylammonium)). (2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylate)
C13H8F3N2O2,C8H12N
CrystEngComm (2010) 12, 11 3634
a=12.4158(6)Å b=5.5535(2)Å c=28.1619(14)Å
α=90° β=94.203(2)° γ=90°
(2-chloro-4-nitrobenzoate)(2-amino-5-bromopyridinium)
C7H3ClNO4,C5H6BrN2
CrystEngComm (2015) 17, 19 3591
a=3.9305(2)Å b=12.4261(6)Å c=13.8457(7)Å
α=94.312(2)° β=91.431(2)° γ=96.374(2)°
(2-chloro-4-nitrobenzoic acid)(2-bromopyridine)
C7H4ClNO4,C5H4BrN
CrystEngComm (2015) 17, 19 3591
a=8.2583(7)Å b=9.0938(7)Å c=9.1385(7)Å
α=88.094(5)° β=77.372(5)° γ=80.171(5)°
(2-chloro-4-nitrobenzoic acid)(3-amino-2-bromopyridine)
C7H4ClNO4,C5H5BrN2
CrystEngComm (2015) 17, 19 3591
a=9.8994(3)Å b=11.9370(4)Å c=13.4905(6)Å
α=110.222(2)° β=96.641(2)° γ=107.0590(10)°
(2-chloro-4-nitrobenzoic acid)(3-amino-2-chloropyridine)
C7H4ClNO4,C5H5ClN2
CrystEngComm (2015) 17, 19 3591
a=7.0984(2)Å b=24.0534(7)Å c=15.7748(5)Å
α=90° β=93.424(2)° γ=90°
(2-chloro-4-nitrobenzoic acid)(2-amino-5-nitropyridine)
C7H4ClNO4,C5H5N3O2
CrystEngComm (2015) 17, 19 3591
a=3.7370(3)Å b=12.6714(11)Å c=14.3717(13)Å
α=90° β=94.984(2)° γ=90°
(2-chloro-4-nitrobenzoate)(2-amino-3-bromopyridinium)
C7H3ClNO4,C5H6BrN2
CrystEngComm (2015) 17, 19 3591
a=6.4350(2)Å b=10.3354(3)Å c=11.2546(4)Å
α=98.577(2)° β=105.0740(10)° γ=98.022(2)°
(2-chloro-4-nitrobenzoic acid)(2-chloro-3-hydroxypyridine)
C7H4ClNO4,C5H4ClNO
CrystEngComm (2015) 17, 19 3591
a=6.1583(2)Å b=9.9176(2)Å c=11.1477(3)Å
α=83.332(2)° β=76.2620(10)° γ=77.0530(10)°
(2-chloro-4-nitrobenzoate)(2-amino-5-chloropyridinium)
C7H3ClNO4,C5H6ClN2
CrystEngComm (2015) 17, 19 3591
a=3.8601(2)Å b=12.3629(6)Å c=13.9025(7)Å
α=93.742(2)° β=91.893(2)° γ=96.066(2)°
C14H13ClN2O4
C14H13ClN2O4
CrystEngComm (2015) 17, 19 3591
a=15.5907(12)Å b=25.242(2)Å c=7.1987(6)Å
α=90° β=100.654(5)° γ=90°
2(C8H12N),I4Zn
2(C8H12N),I4Zn
CrystEngComm (2011) 13, 10 3485
a=8.2036(4)Å b=26.8324(16)Å c=10.9880(6)Å
α=90.00° β=90.202(4)° γ=90.00°
2(C8H12N),CdI4
2(C8H12N),CdI4
CrystEngComm (2011) 13, 10 3485
a=10.940(2)Å b=8.214(2)Å c=13.556(3)Å
α=90.00° β=99.132(17)° γ=90.00°
2(C8H12N),Br4Hg
2(C8H12N),Br4Hg
CrystEngComm (2011) 13, 10 3485
a=7.8392(16)Å b=25.756(5)Å c=11.016(2)Å
α=90.00° β=91.03(3)° γ=90.00°
2(C8H12N),HgI4
2(C8H12N),HgI4
CrystEngComm (2011) 13, 10 3485
a=10.8319(16)Å b=8.3960(12)Å c=13.5792(19)Å
α=90.00° β=98.660(3)° γ=90.00°
2(C8H12N),BrCl2IZn
2(C8H12N),BrCl2IZn
CrystEngComm (2011) 13, 10 3485
a=7.6962(17)Å b=25.541(4)Å c=11.1314(19)Å
α=90.00° β=91.782(16)° γ=90.00°
Bis(nicotinamide).(citric acid)
C6H7.70O7,C6H6.30N2O,C6H6N2O
CrystEngComm (2010) 12, 7 2029
a=5.3769(4)Å b=11.3121(8)Å c=16.9006(11)Å
α=101.325(3)° β=96.441(3)° γ=103.112(3)°
(malonic acid).(isonicotinic acid hydrazide)2
2(C6H7N3O),C3H4O4
CrystEngComm (2010) 12, 10 2856
a=7.7489(15)Å b=28.027(6)Å c=3.8702(8)Å
α=90° β=90° γ=90°
(glutaric acid).(isonicotinic acid hydrazide)
C6H7N3O,C5H8O4
CrystEngComm (2010) 12, 10 2856
a=5.0641(5)Å b=8.1495(10)Å c=16.3114(17)Å
α=76.668(10)° β=81.845(8)° γ=73.046(10)°
(adipic acid).(isonicotinic acid hydrazide)2
C6H10O4,2(C6H7N3O)
CrystEngComm (2010) 12, 10 2856
a=6.3361(4)Å b=3.8795(2)Å c=39.723(2)Å
α=90° β=90.122(5)° γ=90°
(succinic acid).(isonicotinic acid hydrazide)2
C6H7N3O,0.5(C4H6O4)
CrystEngComm (2010) 12, 10 2856
a=6.9976(4)Å b=19.5601(10)Å c=7.1495(5)Å
α=90° β=114.892(8)° γ=90°
(pimelic acid).(isonicotinic acid hydrazide)
C7H12O4,C6H7N3O
CrystEngComm (2010) 12, 10 2856
a=5.1055(5)Å b=7.4175(6)Å c=19.3653(15)Å
α=94.328(6)° β=93.120(6)° γ=103.660(7)°
(3-hydroxybenzoic acid).((Z)-N'-(butan-2- ylidene)isonicotinohydrazide)
C10H13N3O,C7H6O3
CrystEngComm (2010) 12, 10 2856
a=19.8053(8)Å b=8.4686(4)Å c=10.0248(4)Å
α=90° β=99.567(4)° γ=90°
(3-hydroxybenzoic acid).(N'-(propan-2- ylidene)isonicotinohydrazide)
C9H11N3O,C7H6O3
CrystEngComm (2010) 12, 10 2856
a=8.6520(3)Å b=20.8180(8)Å c=8.7850(4)Å
α=90° β=101.679(4)° γ=90°
Bis(2-ethanolammonium)tetraiodoplumbate(ii)
I4Pb,2(C2H8NO)
CrystEngComm (2010) 12, 4 1290
a=10.167(3)Å b=9.038(3)Å c=8.930(3)Å
α=90° β=100.572(5)° γ=90°
Bis(3-propanolammonium)tetraiodoplumbate(ii)
I4Pb,2(C3H10NO)
CrystEngComm (2010) 12, 4 1290
a=10.631(3)Å b=9.199(3)Å c=9.207(3)Å
α=90° β=93.057(6)° γ=90°
Bis(2-iodoethylammonium)tetraiodoplumbate(ii)
I4Pb,2(C2H7IN)
CrystEngComm (2010) 12, 4 1290
a=12.5520(9)Å b=8.7614(6)Å c=8.6441(6)Å
α=90° β=97.994(2)° γ=90°
Bis(4-iodobutylammonium)tetraiodoplumbate(ii)
2(C4H11IN),I4Pb
CrystEngComm (2010) 12, 4 1290
a=15.3677(8)Å b=8.2431(4)Å c=9.0441(4)Å
α=90° β=91.905(1)° γ=90°
Bis(5-iodopentylammonium)tetraiodoplumbate(ii)
2(C5H13IN),I4Pb
CrystEngComm (2010) 12, 4 1290
a=16.2583(11)Å b=8.9028(5)Å c=8.6261(6)Å
α=90° β=90.071(4)° γ=90°
Bis(6-iodohexylammonium)tetraiodoplumbste(ii)
2(C6H15IN),I4Pb
CrystEngComm (2010) 12, 4 1290
a=9.2206(4)Å b=8.8513(4)Å c=31.9795(15)Å
α=90° β=90° γ=90°
(2,2'-dithiodiethanammonium)tetraiodoplumbate(ii)
I8Pb2,2(C4H14N2S2)
CrystEngComm (2010) 12, 4 1290
a=17.795(1)Å b=8.5195(7)Å c=23.1666(15)Å
α=90° β=98.719(5)° γ=90°
Bis(2,2'-dithiodiethanammonium)pentaiodoplumbate(ii) iodide
2(C4H14N2S2),I5Pb,I
CrystEngComm (2010) 12, 4 1290
a=11.3748(2)Å b=8.7290(1)Å c=29.2867(4)Å
α=90° β=95.004(1)° γ=90°
H4N,C4H5O4
H4N,C4H5O4
Acta Crystallographica Section C (2019) 75, 2 208-212
a=9.3716(14)Å b=11.7529(18)Å c=11.2357(16)Å
α=90° β=90.187(9)° γ=90°
4-<i>tert</i>-Butylbenzoic acid--isoniazid
C6H7N3O,C11H14O2
Acta Crystallographica Section C (2019) 75, 2
a=6.6076(2)Å b=7.6668(2)Å c=16.5297(5)Å
α=94.565(2)° β=93.480(2)° γ=94.758(2)°
4-<i>tert</i>-Butylbenzoic acid--<i>N</i>'-(propan-2-ylidene)isonicotinohydrazide
C9H11N3O,C11H14O2
Acta Crystallographica Section C (2019) 75, 2
a=14.2337(6)Å b=13.7116(5)Å c=20.3233(8)Å
α=90° β=99.298(2)° γ=90°
4-<i>tert</i>-Butylbenzoic acid--<i>N</i>'-(butan-2-ylidene)isonicotinohydrazide
C10H13N3O,C11H14O2
Acta Crystallographica Section C (2019) 75, 2
a=14.7663(4)Å b=13.7022(4)Å c=20.4647(6)Å
α=90° β=99.279(2)° γ=90°
4-<i>tert</i>-Butylbenzoic acid--<i>N</i>'-(diphenylmethylene)isonicotinohydrazide
C19H15N3O,C11H14O2
Acta Crystallographica Section C (2019) 75, 2
a=7.69670(10)Å b=10.1984(2)Å c=15.9931(3)Å
α=90° β=93.5050(10)° γ=90°
4-<i>tert</i>-Butylbenzoic acid--<i>N</i>'-(4-hydroxy-4-methylpentan-2-ylidene)isonicotinohydrazide
C12H17N3O2,C11H14O2
Acta Crystallographica Section C (2019) 75, 2
a=20.3803(8)Å b=6.9598(3)Å c=17.2533(7)Å
α=90° β=107.8380(10)° γ=90°
4-Hydroxybenzophenone
C13H10O2
Acta Crystallographica Section C (2018) 74, 4
a=15.0087(16)Å b=13.8489(13)Å c=19.520(2)Å
α=90° β=90° γ=90°
4,4'-Dimethylbenzophenone
C15H14O1
Acta Crystallographica Section C (2018) 74, 4
a=9.4796(14)Å b=9.4796(14)Å c=11.164(3)Å
α=90° β=90° γ=120°
4-(Dimethylamino)benzophenone
C15H15N1O1
Acta Crystallographica Section C (2018) 74, 4
a=7.7442(3)Å b=11.7730(4)Å c=26.2562(11)Å
α=90° β=90° γ=90°
4,4'-Dimethylbenzophenone
C15H14O1
Acta Crystallographica Section C (2018) 74, 4
a=12.1952(10)Å b=7.8601(7)Å c=12.0734(12)Å
α=90° β=90° γ=90°
4,4'-Dimethylbenzophenone
C15H14O
Acta Crystallographica Section C (2018) 74, 4
a=25.369(3)Å b=6.0310(7)Å c=15.256(2)Å
α=90° β=97.788(4)° γ=90°
Theophylline--3,4-dihydroxybenzoic acid (1/1)
C7H8N4O2,C7H6O4
Acta Crystallographica Section C (2018) 74, 6
a=6.7095(3)Å b=13.7764(6)Å c=30.7205(15)Å
α=90° β=90° γ=90°
Bis(cyclohexanecarboxylic acid)(hexamethylenetetramine)
C6H12N4,2(C7H12O2)
Acta Crystallographica Section B (2011) 67, 2 177-192
a=6.03410(10)Å b=30.9087(5)Å c=11.7024(2)Å
α=90° β=103.3660(10)° γ=90°
Bis(para-flourobenzoic acid).(hexamethylenetetramine)
C6H12N4,2(C7H5FO2)
Acta Crystallographica Section B (2011) 67, 2 177-192
a=6.15290(10)Å b=26.9424(6)Å c=11.8758(3)Å
α=90° β=100.5530(10)° γ=90°
Bis(toluidine carboxylic acid).(hexamethylenetetramine)
C6H12N4,2(C8H8O2)
Acta Crystallographica Section B (2011) 67, 2 177-192
a=6.1754(18)Å b=28.234(7)Å c=12.154(3)Å
α=90° β=99.869(15)° γ=90°
Bis(cinnamic acid).(hexamethylenetetramine)
C6H12N4,2(C9H8O2)
Acta Crystallographica Section B (2011) 67, 2 177-192
a=30.8030(6)Å b=9.6904(2)Å c=7.36550(10)Å
α=90° β=90° γ=90°
Bis(4-nitrobenzoic acid).(hexamethylenetetramine) dihydrate
C6H12N4,2(C7H5NO4),2(H2O)
Acta Crystallographica Section B (2011) 67, 2 177-192
a=12.0807(4)Å b=7.4730(2)Å c=25.0633(7)Å
α=90° β=98.9090(10)° γ=90°
(cis-cyclohexane-1,4-dicarboxylic acid).(hexamethylenetetramine)
C8H12O4,C6H12N4
Acta Crystallographica Section B (2011) 67, 2 177-192
a=5.9169(4)Å b=21.6383(15)Å c=6.1135(4)Å
α=90° β=108.0280(10)° γ=90°
(trans-cyclohexane-1,4-dicarboxylic acid).(hexamethylenetetramine)
C8H12O4,C6H12N4
Acta Crystallographica Section B (2011) 67, 2 177-192
a=23.7999(4)Å b=44.9245(8)Å c=5.78040(10)Å
α=90° β=90° γ=90°
(N-(2,6-difluorophenyl)formamide).(N-(2,6-dichlorophenyl)formamide) 0.73:0.27
C7H5Cl1.46F0.54NO
Acta Crystallographica Section B (2014) 70, 1 106-114
a=8.5220(2)Å b=12.2910(3)Å c=14.3090(4)Å
α=90° β=90° γ=90°
(N-(2,6-dichlorophenyl)thioamide).(N-(2,6-dimethylphenyl)thioamide) 0.11:0.89
C8.78H10.35Cl0.22NS
Acta Crystallographica Section B (2014) 70, 1 106-114
a=9.20800(10)Å b=13.1420(2)Å c=14.6170(3)Å
α=90° β=90° γ=90°
(N-(2,6-dichlorophenyl)formamide).(N-(2,6-dimethylphenyl)formamide) 0.48:0.52
C8.03H8.10Cl0.97NO
Acta Crystallographica Section B (2014) 70, 1 106-114
a=8.5073(12)Å b=13.093(2)Å c=14.448(2)Å
α=90° β=90° γ=90°
(N-(2,6-diisopropylphenyl)formamide). (N-(2,6-diisopropylphenyl)thioamide) 0.54:0.46
C13H19NO0.54S0.46
Acta Crystallographica Section B (2014) 70, 1 106-114
a=9.0220(10)Å b=9.0030(9)Å c=16.0050(16)Å
α=90° β=103.170(5)° γ=90°
Bis(butylammonium)tetraiodoplumbate(II)
2(C4H12N),I4Pb
Acta Crystallographica Section B (2007) 63, 5 735-747
a=8.87640(10)Å b=8.69250(10)Å c=27.6014(5)Å
α=90° β=90° γ=90°
Bis(butylammonium)tetraiodoplumbate(II)
2(C4H12N),I4Pb
Acta Crystallographica Section B (2007) 63, 5 735-747
a=8.4280(19)Å b=8.986(2)Å c=26.233(6)Å
α=90° β=90° γ=90°
Bis(pentylammonium)tetraiodoplumbate(II)
2(C5H14N),I4Pb
Acta Crystallographica Section B (2007) 63, 5 735-747
a=8.4716(18)Å b=9.007(2)Å c=14.784(3)Å
α=90° β=100.881(4)° γ=90°
Bis(hexylammonium)tetraiodoplumbate(II)
2(C6H16N),I4Pb
Acta Crystallographica Section B (2007) 63, 5 735-747
a=8.643(4)Å b=8.845(4)Å c=16.052(7)Å
α=90° β=91.985(8)° γ=90°